Features of Autoimmune Hepatitis in Patients With Drug-induced Liver Injury.

TitleFeatures of Autoimmune Hepatitis in Patients With Drug-induced Liver Injury.
Publication TypeJournal Article
Year of Publication2017
AuthorsDe Boer YS, Kosinski AS, Urban TJ, Zhao Z, Long N, Chalasani N, Kleiner DE, Hoofnagle JH
Corporate AuthorsDrug-Induced Liver Injury Network
JournalClin Gastroenterol Hepatol
Volume15
Issue1
Pagination103-112.e2
Date Published2017 01
ISSN1542-7714
KeywordsAdolescent, Adult, Aged, Aged, 80 and over, Anti-Infective Agents, Antihypertensive Agents, Autoantibodies, Chemical and Drug Induced Liver Injury, Female, Hepatitis, Autoimmune, HLA Antigens, Humans, Longitudinal Studies, Male, Middle Aged, Prospective Studies, Severity of Illness Index, Young Adult
Abstract

BACKGROUND & AIMS: Drug-induced liver injury (DILI) has features similar to those of other liver diseases including autoimmune hepatitis (AIH). We aimed to characterize the clinical and autoimmune features of liver injury caused by nitrofurantoin, minocycline, methyldopa, or hydralazine.

METHODS: We analyzed data from 88 cases of DILI attributed to nitrofurantoin, minocycline, methyldopa, or hydralazine included in the Drug-Induced Liver Injury Network prospective study from 2004 through 2014. Sera were collected from patients at baseline and follow-up examination and tested for levels of immunoglobulin G (IgG), antibodies to nuclear antigen (ANA), smooth muscle (SMA), and soluble liver antigen (SLA). An autoimmune score was derived on the basis of increases in levels of IgG, ANA, SMA, and SLA (assigned values of 0, 1+, or 2+). AIH-associated HLA-DRB1*03:01 and HLA-DRB1*04:01 allele frequencies were compared with those of the general population (controls).

RESULTS: Of the 88 cases, 80 were women (91%), 74% had hepatocellular injury, and 25% had severe injury. At the onset of DILI, 39% of cases had increased levels of IgG, 72% had increased levels of ANA, 60% had increased levels of SMA, and none had increases in SLA. A phenotype of autoimmunity (autoimmune score ≥2) was observed in 82% of cases attributed to nitrofurantoin and 73% of cases attributed to minocycline (73%) but only 55% of cases attributed to methyldopa and 43% of cases attributed to hydralazine (P = .16 for nitrofurantoin and minocycline vs methyldopa and hydralazine). We observed a decrease in numbers of serum samples positive for ANA (P = .01) or SMA (P < .001) and in autoimmune scores (P < .001) between DILI onset and follow-up. Similar percentages of patients with DILI had HLA-DRB1*03:01 (15%) and HLA-DRB1*04:01 (9%) as controls (12% and 9%, respectively).

CONCLUSIONS: In analysis of data from the DILIN prospective study, we found that most cases of DILI attributed to nitrofurantoin or minocycline and about half of cases that were due to methyldopa and hydralazine have a phenotype of autoimmunity similar to AIH. These features decrease with recovery of the injury and are not associated with the typical HLA alleles found in patients with idiopathic AIH.

DOI10.1016/j.cgh.2016.05.043
Alternate JournalClin Gastroenterol Hepatol
PubMed ID27311619
PubMed Central IDPMC5370577
Grant ListU01 DK065211 / DK / NIDDK NIH HHS / United States
R21 DK089464 / DK / NIDDK NIH HHS / United States
U01 DK083020 / DK / NIDDK NIH HHS / United States
U01 DK065201 / DK / NIDDK NIH HHS / United States
U01 DK100928 / DK / NIDDK NIH HHS / United States
U01 DK065176 / DK / NIDDK NIH HHS / United States
Z01 BC010686-03 / / Intramural NIH HHS / United States
Z99 CL999999 / / Intramural NIH HHS / United States
Z99 DK999999 / / Intramural NIH HHS / United States
Related Faculty: 
Zhen Zhao, Ph.D.

Pathology & Laboratory Medicine 1300 York Avenue New York, NY 10065 Phone: (212) 746-6464
Surgical Pathology: (212) 746-2700